Compounds > n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea
Page last updated: 2024-09-03

n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Neoplasms

n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea has been researched along with Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armand, JP; Cellarier, E; Cholle, P; Curé, H; Labarre, P; Madelmont, JC; Marchenay, C; Maurizis, JC; Ouabdesselam, R; Terret, C1
Godenèche, D; Madelmont, JC; Mathé, G; Meyniel, G; Misset, JL; Triana, BK1

Trials

2 trial(s) available for n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Neoplasms

ArticleYear
Pharmacokinetic study of cystemustine, administered on a weekly schedule in cancer patients.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:5

    Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Linear Models; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Nitrosourea Compounds; Probability; Survival Analysis; Treatment Outcome

2002
Phase I trial of cystemustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation scheme.
    Drugs under experimental and clinical research, 1992, Volume: 18, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Female; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasms; Nitrosourea Compounds

1992